The main clinical features of this 58-year-old female patient were laboratory evidence of leucopenia and cholestasis, and biopsy features of fatty liver parenchyma degeneration with granulocytic portal infiltration and bile stasis, demonstrated 20 days after the initiation of antithyroid therapy with 20 mg methimazole daily.
bile stasis
methimazole
cholestasis
methimazole
fatty liver parenchyma degeneration
methimazole
leucopenia
methimazole
granulocytic portal infiltration
methimazole